antimicrobial and antibiotic products market Archives - Business Intelligence

Tag: antimicrobial and antibiotic products market

biosimilars market

Themes Shaping the Global Biosimilars Market and What Players Can Do to Stand Out

The global biosimilars market is set for continued growth owing to patent expirations of some of the best-known biologics in the coming years. Despite many practical biosimilars challenges in Europe and the US, both these regions will continue to mature and offer growth opportunities to players in the sector. However, the downward price pressure in the biosimilars market indicates intense competition among key players in the sector. In this scenario, a key differentiator for biosimilars companies will be the ability to design and implement new development and commercial models. By doing so, players can offset the impact of declining prices and rising competition. Our biosimilars market forecast estimates that sales in the sector will surpass $ 10 billion in size by 2022. In this article, healthcare industry experts at Infiniti Research identify some top-of-mind themes that are set to shape the biosimilars market in the years to come and also evaluates what players can do to stand out in the dynamic market.

Although the biosimilars industry has developed rapidly and regulation has advanced significantly over the years with approval processes now in place in many countries, there may be several opportunities to further streamline the regulatory process and accelerate path to market. RFP to know how we can help you effectively identify and capitalize on them before they turn into lost opportunities.

Market development in the US and Europe

Due to the increasing acceptance of biosimilars as an equal to patented drugs in terms of safety, efficacy, immunogenicity, the sales in the biosimilars market in Europe is growing at an unprecedented rate. However, the progress in the biosimilars market across the European region remains uneven. The demand for retail products and self-injectable biologics have weaker demand. This indicates reflects to lower levels of awareness in these segments when compared to hospital-administered products. In contrast, the biosimilars market growth in the US remains fairly flat. In the US, only three biosimilars are currently actively marketed while others remain tied up in patent disputes or are awaiting patent expiry. Furthermore, several regulatory efforts in progress in the US add to the challenges of players in the US biosimilars market.

Price management to create value

Pricing is a vital factor that plays a crucial role in the success of a biosimilar product. Price optimization helps manufacturers create greater leverage in its commercial budget. This can, in turn, be used to enhance competitive positioning, improve business growth and even create product differentiation in the biosimilars market. As in the generics and MedTech sectors, a sound price-to-volume model is vital in the biosimilars market to make the right tradeoffs across accounts. A strong model can better support contract management based on a real-time understanding of the biosimilars market. Moreover, it can also enable quick decisions and help manufacturers calibrate risk/reward ratios.

Want more insights into our solutions portfolio?

Agile go-to-market strategies

Given the intense market competition, biosimilar companies are gradually evolving into highly technical and specialized organizations. As the current generation of biosimilars is complex in comparison to the earlier generations, it is essential to ensure that they are tested and launched in a much more restricted analytical and clinical environment. Additionally, biosimilars companies must also have the ability to take bold decisions on where to invest and identify ways to set up a commercial footprint. It is also important for companies in the sector to demonstrate the ability to rapidly trade-off resources based on dynamic market conditions.

Want to identify unmet needs and investment opportunities in the biosimilars market? Learn how our solutions can help you.

Competitor analysis

Antibiotic Drugs Provider Leverages the Use of Strategic Analysis to Assess Market Potential

Over the past few years, the spending on healthcare has overtaken all other expenses due to the increasing incidence of infectious and chronic diseases across the globe. Individuals are also investing heavily in antibiotic drugs to remain vibrant and healthy. Additionally, the costs associated with antibiotic drugs and healthcare is nearing its saturation, and governments across the globe are taking robust initiatives to promote healthcare services. However, such efforts have affected the antibiotic drugs landscape with numerous competitors offering various variants of antibiotic drugs. As a result, antibiotic drugs manufacturers have started adopting robust strategic analysis solutions to remain competitive and gain a stronger foothold in the healthcare industry.IR_Brochure

Infiniti’s strategic analysis solution assists clients to identify the social, economic, and political changes prevailing in the antibiotic drugs landscape. Additionally, the client can determine the technologies prevailing in the market and renovate their current technologies to enter different niche markets.

The Business Challenge

The primary objective of the antibiotic drugs client was to gain a deeper understanding of the product portfolios and strategies of competitors to devise and sustain their product offerings in the healthcare industry. Additionally, with the increasing competition levels in the market, the client was facing difficulties in assessing the market potential of their key competitors in the industry. As a result, they wanted to understand the competitors, offerings, and leverage strategic analysis to enter into various niche market segments.

Our Approach

To assess the market potential, the client contacted Infiniti’s team of strategic analysis experts. With years of experience in assisting clients to evaluate market potential and benchmark their strengths across various industries, the strategic analysis experts carried out a unified approach comprising of interviews and discussions with leading stakeholders in the healthcare industry. Additionally, to cater to the challenges, the strategic analysis experts also gathered information from various proprietary sources such as health care advisors, hospitals, and healthcare newsletters to gain a complete view of the competitors, their offerings, and current technologies in the antibiotic drugs market space.

Strategic AnalysisWant more information about our strategic analysis solutions?

Ask an analyst

Strategic Analysis Solution Benefits:

  • Identified the issues prevailing in the antibiotic drugs market space
  • Identified the target segments in terms of demographics and psychographics
  • Analyzed the potential market growth aspects
  • Devised a robust SWOT analysis to gain an understanding of the current position in the market
  • Evaluated the value chain of the customers

Benefits of Our Integrated Approach

In a mere span of 12 weeks, the client was able to perform a competitor analysis, situation analysis, and self-evaluation of the antibiotic drugs in the healthcare market. Additionally, the client was able to quantify the effectiveness of the current strategy and conduct a robust SWOT analysis to assess the market potential. This engagement also helped the client allocate resources to enhance their product offerings.

A must-read case study for strategy experts and decision makers looking to develop an understanding of the antibiotic drugs industry.

IR_RFP

Customer Survey to Assess Awareness of Antimicrobial and Antibiotic Products in India

Business Challenge
A leading pharmaceutical company wanted to understand the level of awareness of antimicrobial and antibiotic products among pet owners in India.
Situation
The client, as part of its expansion strategy, was looking to introduce new antimicrobial and antibiotic products for pets in the Indian market and wanted to understand the level of awareness regarding similar products among potential customers.
Approach
We conducted telephone surveys of both veterinarians and pet owners across multiple cities in India to gather the required information. The collected information was analyzed thoroughly to derive insights on the awareness of the customers.
Impact
The client was able to devise marketing strategies to increase product awareness and thus drive sales.
Close
Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice